Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis

Journal of Digestive Diseases

Volumn 17, Issue 7, 2016, Pages 433-440

  Upala, Sikarin ^a,b   Jaruvongvanich, Veeravich ^c,d   Riangwiwat, Tanawan ^c   Jaruvongvanich, Suthinee ^d   Sanguankeo, Anawin ^a,b  

^a Bassett Medical Center and Columbia University College of Physicians and Surgeons ^*  (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF HAWAII   (United States)

^d KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Campylobacter infection; Helicobacter pylori; insulin resistance; meta analysis; metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; COMPLICATION; HELICOBACTER PYLORI; META ANALYSIS; MICROBIOLOGY; PATHOPHYSIOLOGY; PUBLISHING;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; PUBLICATION BIAS;

EID: 84988963529     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12367     Document Type: Article

References (45)

1. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597–604.
2. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808–25.
3. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–6.
4. Lai CY, Yang TY, Lin CL, Kao CH. Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 2015; 34: 69–74.
5. Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter 2015; 20: 125–32.
6. Shmuely H, Wattad M, Solodky A, Yahav J, Samra Z, Zafrir N. Association of Helicobacter pylori with coronary artery disease and myocardial infarction assessed by myocardial perfusion imaging. Isr Med Assoc J 2014; 16: 341–6.
7. Devaraj S, Rosenson RS, Jialal I. Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am 2004; 33: 431–53.
8. Ando T, Ishikawa T, Takagi T et al. Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter 2013; 18: 158–64.
9. de Luis DA, Garcia Avello A, Lasuncion MA et al. Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. Clin Nutr 1999; 18: 227–31.
10. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J 2010; 103: 190–6.
11. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004; 96: 1470–6.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97.
13. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol 2005; 4: 198–203.
14. Saely CH, Koch L, Schmid F et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006; 29: 901–7.
15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–53.
16. Shin DW, Kwon HT, Kang JM et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol 2012; 46: 840–5.
17. Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603–5.
18. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046–55.
19. Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovasc Diabetol 2006; 5: 25.
20. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007; 121: 229–38.
21. Gunji T, Matsuhashi N, Sato H et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 2008; 103: 3005–10.
22. Eshraghian A, Hashemi SA, Hamidian Jahromi A et al. Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 2009; 54: 1966–70.
23. Manolakis AC, Tiaka EK, Kapsoritakis AN et al. Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance? Diabetologia 2011; 54: 472–4.
24. Naja F, Nasreddine L, Hwalla N et al. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012; 17: 444–51.
25. Hsieh MC, Wang SS, Hsieh YT, Kuo FC, Soon MS, Wu DC. Helicobacter pylori infection associated with high HbA1c and type 2 diabetes. Eur J Clin Invest 2013; 43: 949–56.
26. Bajaj S, Rekwal L, Misra SP, Misra V, Yadav RK, Srivastava A. Association of Helicobacter pylori infection with type 2 diabetes. Indian J Endocrinol Metab 2014; 18: 694–9.
27. Malamug LR, Karnchanasorn R, Samoa R, Chiu KC. The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function, and abnormal glucose tolerance. Scientifica (Cairo) 2014; 2014: 870165.
28. Moretti E, Gonnelli S, Campagna M, Nuti R, Collodel G, Figura N. Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients. Intern Emerg Med 2014; 9: 767–72.
29. Vafaeimanesh J, Parham M, Seyyedmajidi M, Bagherzadeh M. Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population. Scientific World Journal 2014; 2014: 391250.
30. Chen TP, Hung HF, Chen MK et al. Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study. Helicobacter 2015; 20: 184–91.
31. Işiktaş Sayılar E, Çelik B, Dumlu Ş. Relationship between Helicobacter pylori infection and metabolic syndrome. Turk J Gastroenterol 2015; 26: 468–73.
32. Kayar Y, Pamukçu Ö, Eroğlu H, Kalkan Erol K, Ilhan A, Kocaman O. Relationship between Helicobacter pylori infections in diabetic patients and inflammations, metabolic syndrome, and complications. Int J Chronic Dis 2015; 2015: 290128.
33. Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects. Obesity (Silver Spring) 2013; 21: 535–7.
34. Chen LW, Chien CY, Yang KJ, Kuo SF, Chen CH, Chien RN. Helicobacter pylori infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: a community-based study. PLoS One 2015; 10: e0128671.
35. Vafaeimanesh J, Heidari A, Effatpanah M, Parham M. Serum adiponectin level in diabetic patients with and without Helicobacter pylori infection: is there any difference?. Scientific World Journal 2014; 2014: 402685.
36. Mendall MA, Goggin PM, Molineaux N et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437–9.
37. Pietroiusti A, Diomedi M, Silvestrini M et al. Cytotoxin-associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002; 106: 580–4.
38. Aslan M, Horoz M, Nazligul Y et al. Insulin resistance in H. pylori infection and its association with oxidative stress. World J Gastroenterol 2006; 12: 6865–8.
39. Corcoran PA, Atherton JC, Kerrigan SW et al. The effect of different strains of Helicobacter pylori on platelet aggregation. Can J Gastroenterol 2007; 21: 367–70.
40. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999; 319: 1157–62.
41. Migneco A, Ojetti V, Specchia L et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 2003; 8: 585–9.
42. Oshima T, Ozono R, Yano Y et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 1219–22.
43. Ozdem S, Akcam M, Yilmaz A, Artan R. Insulin resistance in children with Helicobacter pylori infection. J Endocrinol Invest 2007; 30: 236–40.
44. Takashima T, Adachi K, Kawamura A et al. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter 2002; 7: 86–90.
45. Kanbay M, Gür G, Yücel M, Yilmaz U, Boyacioğlu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 2005; 50: 1228–31.